207 related articles for article (PubMed ID: 11996084)
1. Permeability characteristics of calu-3 human bronchial epithelial cells: in vitro-in vivo correlation to predict lung absorption in rats.
Mathia NR; Timoszyk J; Stetsko PI; Megill JR; Smith RL; Wall DA
J Drug Target; 2002 Feb; 10(1):31-40. PubMed ID: 11996084
[TBL] [Abstract][Full Text] [Related]
2. The characterization of the human cell line Calu-3 under different culture conditions and its use as an optimized in vitro model to investigate bronchial epithelial function.
Kreft ME; Jerman UD; Lasič E; Hevir-Kene N; Rižner TL; Peternel L; Kristan K
Eur J Pharm Sci; 2015 Mar; 69():1-9. PubMed ID: 25555374
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of layers of the rat airway epithelial cell line RL-65 for permeability screening of inhaled drug candidates.
Hutter V; Hilgendorf C; Cooper A; Zann V; Pritchard DI; Bosquillon C
Eur J Pharm Sci; 2012 Sep; 47(2):481-9. PubMed ID: 22820031
[TBL] [Abstract][Full Text] [Related]
4. Modulation of tight junctions does not predict oral absorption of hydrophilic compounds: use of Caco-2 and Calu-3 cells.
Kamath AV; Morrison RA; Mathias NR; Dando SA; Marino AM; Chong S
Arch Pharm Res; 2007 Aug; 30(8):1002-7. PubMed ID: 17879754
[TBL] [Abstract][Full Text] [Related]
5. Quantitative estimation of drug permeation through nasal mucosa using in vitro membrane permeability across Calu-3 cell layers for predicting in vivo bioavailability after intranasal administration to rats.
Inoue D; Furubayashi T; Tanaka A; Sakane T; Sugano K
Eur J Pharm Biopharm; 2020 Apr; 149():145-153. PubMed ID: 32057906
[TBL] [Abstract][Full Text] [Related]
6. Drug absorption from the isolated perfused rat lung--correlations with drug physicochemical properties and epithelial permeability.
Tronde A; Nordén B; Jeppsson AB; Brunmark P; Nilsson E; Lennernäs H; Bengtsson UH
J Drug Target; 2003 Jan; 11(1):61-74. PubMed ID: 12852442
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary delivery of low molecular weight heparins.
Yang T; Mustafa F; Bai S; Ahsan F
Pharm Res; 2004 Nov; 21(11):2009-16. PubMed ID: 15587922
[TBL] [Abstract][Full Text] [Related]
8. Optimisation of culture conditions to develop an in vitro pulmonary permeability model.
Geys J; Nemery B; Hoet PH
Toxicol In Vitro; 2007 Oct; 21(7):1215-9. PubMed ID: 17629671
[TBL] [Abstract][Full Text] [Related]
9. A Comparison of Drug Transport in Pulmonary Absorption Models: Isolated Perfused rat Lungs, Respiratory Epithelial Cell Lines and Primary Cell Culture.
Bosquillon C; Madlova M; Patel N; Clear N; Forbes B
Pharm Res; 2017 Dec; 34(12):2532-2540. PubMed ID: 28924829
[TBL] [Abstract][Full Text] [Related]
10. Functional and cytometric examination of different human lung epithelial cell types as drug transport barriers.
Min KA; Rosania GR; Kim CK; Shin MC
Arch Pharm Res; 2016 Mar; 39(3):359-69. PubMed ID: 26746641
[TBL] [Abstract][Full Text] [Related]
11. Modelling the bronchial barrier in pulmonary drug delivery: A human bronchial epithelial cell line supplemented with human tracheal mucus.
Murgia X; Yasar H; Carvalho-Wodarz C; Loretz B; Gordon S; Schwarzkopf K; Schaefer U; Lehr CM
Eur J Pharm Biopharm; 2017 Sep; 118():79-88. PubMed ID: 28373109
[TBL] [Abstract][Full Text] [Related]
12. Culture of Calu-3 cells at the air interface provides a representative model of the airway epithelial barrier.
Grainger CI; Greenwell LL; Lockley DJ; Martin GP; Forbes B
Pharm Res; 2006 Jul; 23(7):1482-90. PubMed ID: 16779708
[TBL] [Abstract][Full Text] [Related]
13. Establishing a liquid-covered culture of polarized human airway epithelial Calu-3 cells to study host cell response to respiratory pathogens in vitro.
Harcourt JL; Haynes LM
J Vis Exp; 2013 Feb; (72):. PubMed ID: 23426201
[TBL] [Abstract][Full Text] [Related]
14. Serially passaged human nasal epithelial cell monolayer for in vitro drug transport studies.
Yoo JW; Kim YS; Lee SH; Lee MK; Roh HJ; Jhun BH; Lee CH; Kim DD
Pharm Res; 2003 Oct; 20(10):1690-6. PubMed ID: 14620527
[TBL] [Abstract][Full Text] [Related]
15. Drug transport across pulmonary epithelial cell monolayers: effects of particle size, apical liquid volume, and deposition technique.
Bur M; Huwer H; Muys L; Lehr CM
J Aerosol Med Pulm Drug Deliv; 2010 Jun; 23(3):119-27. PubMed ID: 20073555
[TBL] [Abstract][Full Text] [Related]
16. Insulin aggregation and asymmetric transport across human bronchial epithelial cell monolayers (Calu-3).
Pezron I; Mitra R; Pal D; Mitra AK
J Pharm Sci; 2002 Apr; 91(4):1135-46. PubMed ID: 11948552
[TBL] [Abstract][Full Text] [Related]
17. Indication of transcytotic movement of insulin across human bronchial epithelial cells.
Hussain A; Ahsan F
J Drug Target; 2006 May; 14(4):181-90. PubMed ID: 16777678
[TBL] [Abstract][Full Text] [Related]
18. In-cell Western™ detection of organic cation transporters in bronchial epithelial cell layers cultured at an air-liquid interface on Transwell(®) inserts.
Mukherjee M; Latif ML; Pritchard DI; Bosquillon C
J Pharmacol Toxicol Methods; 2013; 68(2):184-189. PubMed ID: 23764373
[TBL] [Abstract][Full Text] [Related]
19. The cell line NCl-H441 is a useful in vitro model for transport studies of human distal lung epithelial barrier.
Salomon JJ; Muchitsch VE; Gausterer JC; Schwagerus E; Huwer H; Daum N; Lehr CM; Ehrhardt C
Mol Pharm; 2014 Mar; 11(3):995-1006. PubMed ID: 24524365
[TBL] [Abstract][Full Text] [Related]
20. In-vitro respiratory drug absorption models possess nominal functional P-glycoprotein activity.
Madlova M; Bosquillon C; Asker D; Dolezal P; Forbes B
J Pharm Pharmacol; 2009 Mar; 61(3):293-301. PubMed ID: 19222901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
